Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations:a nested case-control study

Objective To examine the association between pre-diagnostic circulating vitamin D concentration, dietary intake of vitamin D and calcium, and the risk of colorectal cancer in European populations. Design Nested case-control study. Setting The study was conducted within the EPIC study, a cohort of more than 520 000 participants from 10 western European countries. Participants 1248 cases of incident colorectal cancer, which developed after enrolment into the cohort, were matched to 1248 controls Main outcome measures Circulating vitamin D concentration (25-hydroxy-vitamin-D, 25-(OH)D) was measured by enzyme immunoassay. Dietary and lifestyle data were obtained from questionnaires. Incidence rate ratios and 95% confidence intervals for the risk of colorectal cancer by 25-(OH)D concentration and levels of dietary calcium and vitamin D intake were estimated from multivariate conditional logistic regression models, with adjustment for potential dietary and other confounders. Results 25-(OH)D concentration showed a strong inverse linear dose-response association with risk of colorectal cancer (P for trend <0.001). Compared with a pre-defined mid-level concentration of 25-(OH)D (50.0-75.0 nmol/l), lower levels were associated with higher colorectal cancer risk (<25.0 nmol/l: incidence rate ratio 1.32 (95% confidence interval 0.87 to 2.01); 25.0-49.9 nmol/l: 1.28 (1.05 to 1.56), and higher concentrations associated with lower risk (75.0-99.9 nmol/l: 0.88 (0.68 to 1.13); ≥100.0 nmol/l: 0.77 (0.56 to 1.06)). In analyses by quintile of 25-(OH)D concentration, patients in the highest quintile had a 40% lower risk of colorectal cancer than did those in the lowest quintile (P<0.001). Subgroup analyses showed a strong association for colon but not rectal cancer (P for heterogeneity=0.048). Greater dietary intake of calcium was associated with a lower colorectal cancer risk. Dietary vitamin D was not associated with disease risk. Findings did not vary by sex and were not altered by corrections for season or month of blood donation. Conclusions The results of this large observational study indicate a strong inverse association between levels of pre-diagnostic 25-(OH)D concentration and risk of colorectal cancer in western European populations. Further randomised trials are needed to assess whether increases in circulating 25-(OH)D concentration can effectively decrease the risk of colorectal cancer.

[1]  Annamaria Colao,et al.  Vitamin D and Cancer , 2012, Front. Endocrin..

[2]  R. Berg,et al.  A Systematic Review and Meta-analysis , 2010 .

[3]  E John Orav,et al.  Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. , 2009, Archives of internal medicine.

[4]  M. Holick,et al.  Vitamin D status: measurement, interpretation, and clinical application. , 2009, Annals of epidemiology.

[5]  B. Kupelnick,et al.  Colorectal Cancer Risk and Dietary Intake of Calcium, Vitamin D, and Dairy Products: A Meta-Analysis of 26,335 Cases From 60 Observational Studies , 2008, Nutrition and cancer.

[6]  R. Koerfer,et al.  Vitamin D in the prevention and treatment of coronary heart disease , 2008, Current opinion in clinical nutrition and metabolic care.

[7]  J. Vandenbroucke,et al.  Practice of Epidemiology What Do Case-Control Studies Estimate? Survey of Methods and Assumptions in Published Case-Control Research , 2008 .

[8]  R. Heaney.  Vitamin D and calcium interactions: functional outcomes. , 2008, The American journal of clinical nutrition.

[9]  J. Meyerhardt,et al.  Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  E. Rimm,et al.  25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. , 2008, Archives of internal medicine.

[11]  Martin Wiseman,et al.  The Second World Cancer Research Fund/American Institute for Cancer Research Expert Report. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective , 2008, Proceedings of the Nutrition Society.

[12]  K. Shankar,et al.  Chronic ethanol consumption leads to disruption of vitamin D3 homeostasis associated with induction of renal 1,25 dihydroxyvitamin D3-24-hydroxylase (CYP24A1). , 2008, Endocrinology.

[13]  J. Yaphe,et al.  Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps. , 2008, The Cochrane database of systematic reviews.

[14]  Jacques Ferlay,et al.  Cancer screening in the European Union. Report on the implementation of the Council Recommendation on cancer screening. , 2008 .

[15]  Sara Gandini,et al.  Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. , 2007, Archives of internal medicine.

[16]  D. Trump,et al.  Vitamin D signalling pathways in cancer: potential for anticancer therapeutics , 2007, Nature Reviews Cancer.

[17]  W. Willett,et al.  A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer. , 2007, Journal of the National Cancer Institute.

[18]  M. Inoue,et al.  Plasma vitamin D and risk of colorectal cancer: the Japan Public Health Center-Based Prospective Study , 2007, British Journal of Cancer.

[19]  R. Recker,et al.  Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. , 2007, The American journal of clinical nutrition.

[20]  Bess Dawson-Hughes,et al.  The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. , 2007, The Journal of clinical endocrinology and metabolism.

[21]  E. Giovannucci,et al.  Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. , 2007, American journal of preventive medicine.

[22]  Eric A. Miller,et al.  Calcium, dietary, and lifestyle factors in the prevention of colorectal adenomas , 2007, Cancer.

[23]  E. Riboli,et al.  The second expert report, Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective , 2007 .

[24]  A. Ascherio,et al.  Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. , 2006, JAMA.

[25]  J. Baron,et al.  Chemoprevention in gastrointestinal cancers: current status. , 2006, Basic & clinical pharmacology & toxicology.

[26]  John Robbins,et al.  Calcium plus vitamin D supplementation and the risk of colorectal cancer. , 2006, The New England journal of medicine.

[27]  H. Boshuizen,et al.  Reliability of biomarkers of iron status, blood lipids, oxidative stress, vitamin D, C-reactive protein and fructosamine in two Dutch cohorts , 2006, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[28]  H. Jha,et al.  Novel tempeh (fermented soyabean) isoflavones inhibit in vivo angiogenesis in the chicken chorioallantoic membrane assay , 2005, British Journal of Nutrition.

[29]  D. Hanley,et al.  Vitamin D insufficiency in North America. , 2005, The Journal of nutrition.

[30]  B. Hollis.  Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. , 2005, The Journal of nutrition.

[31]  Edward Giovannucci,et al.  The epidemiology of vitamin D and cancer incidence and mortality: A review (United States) , 2005, Cancer Causes & Control.

[32]  S. Hankinson,et al.  Plasma vitamin D metabolites and risk of colorectal cancer in women. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[33]  W. Willett,et al.  Dairy foods, calcium, and colorectal cancer: a pooled analysis of 10 cohort studies. , 2004, Journal of the National Cancer Institute.

[34]  P. Lips.  Which circulating level of 25-hydroxyvitamin D is appropriate? , 2004, The Journal of Steroid Biochemistry and Molecular Biology.

[35]  R. Hayes,et al.  Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[36]  D. Albanes,et al.  Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men , 1997, Cancer Causes & Control.

[37]  R. Doll,et al.  Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial , 2003, BMJ : British Medical Journal.

[38]  N E Day,et al.  European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection , 2002, Public Health Nutrition.

[39]  R. Mehta,et al.  Vitamin D and cancer. , 2002, The Journal of nutritional biochemistry.

[40]  H. Boeing,et al.  The use of biomarkers in multicentric studies with particular consideration of iodine, sodium, iron, folate and vitamin D , 2002, European Journal of Clinical Nutrition.

[41]  W. Willett,et al.  Calcium intake and risk of colon cancer in women and men. , 2002, Journal of the National Cancer Institute.

[42]  R. Sinha,et al.  Vitamin D, calcium, and vitamin D receptor polymorphism in colorectal adenomas. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[43]  M. Holick,et al.  25-hydroxyvitamin D-1α-hydroxylase in normal and malignant colon tissue , 2001, The Lancet.

[44]  E. Bajna,et al.  25-Hydroxyvitamin D3-1α-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesis , 2001, Steroids.

[45]  C. Ervin,et al.  Serum 25-Hydroxyvitamin D, Dietary Calcium Intake, and Distal Colorectal Adenoma Risk , 2001, Nutrition and cancer.

[46]  J. Flanagan,et al.  25-hydroxyvitamin D-1alpha-hydroxylase in normal and malignant colon tissue. , 2001, Lancet.

[47]  F. Speizer,et al.  Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and adenomatous polyps of the distal colorectum. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[48]  W. Willett,et al.  Calcium, vitamin D, and colorectal cancer: a review of the epidemiologic evidence. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[49]  K. Helzlsouer,et al.  Colon cancer and serum vitamin D metabolite levels 10-17 years prior to diagnosis. , 1995, American journal of epidemiology.

[50]  S. Ciatto,et al.  Cancer screening in the European Union. , 1994, European journal of cancer.

[51]  M. Kärkkäinen,et al.  Deranged vitamin D metabolism but normal bone mineral density in Finnish noncirrhotic male alcoholics. , 1990, Alcoholism, clinical and experimental research.

[52]  C. Garland,et al.  SERUM 25-HYDROXYVITAMIN D AND COLON CANCER: EIGHT-YEAR PROSPECTIVE STUDY , 1989, The Lancet.

[53]  C. Garland,et al.  Do sunlight and vitamin D reduce the likelihood of colon cancer? , 1980, International journal of epidemiology.

[54]  H. Bartsch,et al.  International Agency for Research on Cancer. , 1969, WHO chronicle.